SANDRA GRIMM to Glioblastoma
This is a "connection" page, showing publications SANDRA GRIMM has written about Glioblastoma.
Connection Strength
0.097
-
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol. 2016 Jan; 126(1):185-192.
Score: 0.097